Evommune, Inc. (EVMN) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$34.7M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$23.85M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$13.33M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA -$22.79M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2024-12-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$34.7M | (m) | (m) | (m) | (m) | $183.00K* | -$20.32M* | (m) | $26.41M | (m) | $0.00* |
|---|
| 2026-03-31 | Reported | -$23.85M | (m) | (m) | (m) | (m) | $83.00K | -$27.50M | (m) | $17.32M | (m) | $0.00 |
|---|
| 2025-09-30 | Reported | (m) | -$13.33M | (m) | $10.00M | (m) | $131.00K* | -$9.63M* | (m) | $19.64M | (m) | $0.00 |
|---|
| 2025-06-30 | Reported | -$22.79M | (m) | (m) | (m) | (m) | $0.00* | -$26.21M* | (m) | $19.64M | (m) | $0.00* |
|---|
| 2025-03-31 | Reported | -$14.83M | (m) | (m) | (m) | (m) | $0.00 | -$23.90M | (m) | $14.36M | (m) | $0.00 |
|---|
| 2024-09-30 | Reported | (m) | -$16.52M | (m) | (m) | (m) | (m) | (m) | (m) | $13.29M | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$80.47M | (m) | (m) | (m) | (m) | $235.00K | -$76.44M | (m) | $74.04M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$69.51M | (m) | (m) | (m) | (m) | $88.00K | -$58.20M | (m) | $64.24M | (m) | $0.00 |
|---|